Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10118044 | 0.85 | CA12 (0.36) | CA12CA1CA2CA9LMNA | |
| SCHEMBL308884 | 0.85 | CA12 (0.36) | CA12CA1CA2CA9LMNA | |
| SCHEMBL308885 | 0.85 | CA12 (0.36) | CA12CA1CA2CA9LMNA | |
| SCHEMBL308886 | 0.85 | CA12 (0.36) | CA12CA1CA2CA9LMNA | |
| SCHEMBL16299274 | 0.77 | CA2 (0.36) | CA12CA1CA2CA9LMNA | |
| SCHEMBL12173952 | 0.74 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL9053790 | 0.73 | TK1 (0.34) | — | |
| SCHEMBL6933961 | 0.73 | PDK1 (0.34) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL21728820 | 0.73 | PDK1 (0.34) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL1626249 | 0.72 | CA2 (0.42) | CA12CA1CA2CA9LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1411954-A2 | MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION | Pharmasset Limited (BB) | 2004-04-28 | — | — | EP | disclosed |
| WO-2002032920-A2 | MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION | PHARMASSET LIMITED (BB) | 2002-04-25 | — | — | WO | disclosed |